Actively Recruiting
Light Therapy Intervention in Individuals With Parkinson's Disease
Led by University of Delaware · Updated on 2025-04-08
20
Participants Needed
1
Research Sites
68 weeks
Total Duration
On this page
Sponsors
U
University of Delaware
Lead Sponsor
N
NeuroThera
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minutes. for this study the therapy will be done 3 times a week for 6 weeks. To measure the potential effects on the therapy in Parkinson symptoms, we will do a set of cognitive and motor test before and after the intervention to measure any changes as well as control for any potential markers such as age, sex, disease level, medication and exercise.
CONDITIONS
Official Title
Light Therapy Intervention in Individuals With Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Parkinson disease
You will not qualify if you...
- Unable to comply with study visit or testing requirements, including going off PD medication for assessments
- Unable to provide consent
- Has a Deep Brain Stimulation (DBS) device
- History of psychiatric disorder
- Has other concurrent movement or neurological conditions such as dystonia, dementia, or epilepsy
- Clinical diagnosis of PD that is not primary or suspected atypical parkinsonism
- History of cancer regardless of treatment
- Recent concussion or facial, neck, or head injury within the last 6 months
- Known injury or disease interfering with motor function (e.g., stroke, traumatic brain injury, neuromuscular disease)
- History of photosensitivity
- Unable to walk unassisted for 2 minutes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Delaware STAR Tower
Newark, Delaware, United States, 19711
Actively Recruiting
Research Team
S
Sara Penuela, PhD student
CONTACT
R
Roxana Burciu, PhD, Associative Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here